WO2010017885A3 - Use of 5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5yl)-3-methyl- penta-2,4-dienoic - Google Patents
Use of 5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5yl)-3-methyl- penta-2,4-dienoic Download PDFInfo
- Publication number
- WO2010017885A3 WO2010017885A3 PCT/EP2009/005406 EP2009005406W WO2010017885A3 WO 2010017885 A3 WO2010017885 A3 WO 2010017885A3 EP 2009005406 W EP2009005406 W EP 2009005406W WO 2010017885 A3 WO2010017885 A3 WO 2010017885A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- benzoxepin
- penta
- dihydro
- methoxy
- dimethyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011522397A JP5764060B2 (en) | 2008-08-12 | 2009-07-27 | Use of 5- (7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzooxepin-5-yl) -3-methyl-penta-2,4-dienoic acid as cosmetic |
EP09777441.8A EP2309974B1 (en) | 2008-08-12 | 2009-07-27 | Use of 5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5-yl)-3-methyl-penta-2,4-dienoic |
US13/058,685 US20110144130A1 (en) | 2008-08-12 | 2009-07-27 | Use of 5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5-yl)-3-methyl-penta-2,4-dienoic acid as a cosmetic |
US13/932,482 US20140017187A1 (en) | 2008-08-12 | 2013-07-01 | Use of 5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5-yl)-3-methyl-penta-2,4-dienoic acid as a cosmetic |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08014354 | 2008-08-12 | ||
EP08014354.8 | 2008-08-12 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/932,482 Division US20140017187A1 (en) | 2008-08-12 | 2013-07-01 | Use of 5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5-yl)-3-methyl-penta-2,4-dienoic acid as a cosmetic |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010017885A2 WO2010017885A2 (en) | 2010-02-18 |
WO2010017885A3 true WO2010017885A3 (en) | 2010-09-02 |
Family
ID=41669381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2009/005406 WO2010017885A2 (en) | 2008-08-12 | 2009-07-27 | Use of 5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5-yl)-3-methyl- penta-2,4-dienoic acid as a cosmetic |
Country Status (4)
Country | Link |
---|---|
US (2) | US20110144130A1 (en) |
EP (1) | EP2309974B1 (en) |
JP (1) | JP5764060B2 (en) |
WO (1) | WO2010017885A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101411838B1 (en) * | 2011-02-09 | 2014-06-27 | 부산대학교 산학협력단 | New compounds having skin whitening, antioxidant and PPAR activity, and medical use thereof |
JP2013179884A (en) * | 2012-03-01 | 2013-09-12 | Mitsubishi Rayon Co Ltd | Nucleic acid microarray for evaluating component relating to melanin cascade and method for evaluating component relating to melanin cascade |
WO2016014819A1 (en) * | 2014-07-23 | 2016-01-28 | Joseph Hutchison | Modifications to access ports for minimally invasive neuro surgery |
KR102487937B1 (en) * | 2014-10-17 | 2023-01-13 | 디에스엠 아이피 어셋츠 비.브이. | Use of a cosmetic composition comprising 10-hydroxystearic acid |
EP3592329A1 (en) * | 2017-03-06 | 2020-01-15 | Merck Patent GmbH | Use of compatible solutes |
CN111467349B (en) * | 2020-05-14 | 2021-06-01 | 华熙生物科技股份有限公司 | Artificial tear and preparation method thereof |
WO2022053416A1 (en) | 2020-09-08 | 2022-03-17 | Merck Patent Gmbh | Improvement of water-holding capacity of skin by oxeglitazar |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225436A (en) * | 1987-05-15 | 1993-07-06 | Schering Corporation | Aryl substituted naphthalene derivatives |
EP0671161A1 (en) * | 1993-12-14 | 1995-09-13 | Marbert GmbH | Ectoine and ectoine derivatives as moisturizing agents in cosmetic preparation |
JPH1135460A (en) * | 1997-07-24 | 1999-02-09 | Kyowa Hakko Kogyo Co Ltd | Pharmaceutical preparation containing dibenzo(b,e)oxepin derivative |
US6596758B1 (en) * | 1998-12-29 | 2003-07-22 | Merck Patent Gmbh | Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030157040A1 (en) * | 1998-08-01 | 2003-08-21 | Merck Patent Gmbh | Use of ectoine or ectoine derivatives in cosmetic formulations |
EP1100457B1 (en) * | 1998-08-01 | 2004-10-06 | MERCK PATENT GmbH | Use of ectoine or ectoine derivatives in cosmetic formulations |
GB9918023D0 (en) * | 1999-07-30 | 1999-09-29 | Unilever Plc | Skin care composition |
FR2845386B1 (en) * | 2002-10-07 | 2006-06-30 | Merck Sante Sas | NOVEL METASTABLES OF BENZOXEPINES USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHODS OF PREPARATION |
JP4732854B2 (en) * | 2005-10-31 | 2011-07-27 | 一丸ファルコス株式会社 | Peroxisome proliferator-responsive receptor activator |
CA2684604A1 (en) * | 2007-05-15 | 2008-11-27 | Puretech Ventures | Methods and compositions for treating skin conditions |
-
2009
- 2009-07-27 US US13/058,685 patent/US20110144130A1/en not_active Abandoned
- 2009-07-27 EP EP09777441.8A patent/EP2309974B1/en not_active Not-in-force
- 2009-07-27 WO PCT/EP2009/005406 patent/WO2010017885A2/en active Application Filing
- 2009-07-27 JP JP2011522397A patent/JP5764060B2/en not_active Expired - Fee Related
-
2013
- 2013-07-01 US US13/932,482 patent/US20140017187A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225436A (en) * | 1987-05-15 | 1993-07-06 | Schering Corporation | Aryl substituted naphthalene derivatives |
EP0671161A1 (en) * | 1993-12-14 | 1995-09-13 | Marbert GmbH | Ectoine and ectoine derivatives as moisturizing agents in cosmetic preparation |
JPH1135460A (en) * | 1997-07-24 | 1999-02-09 | Kyowa Hakko Kogyo Co Ltd | Pharmaceutical preparation containing dibenzo(b,e)oxepin derivative |
US6596758B1 (en) * | 1998-12-29 | 2003-07-22 | Merck Patent Gmbh | Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process |
Also Published As
Publication number | Publication date |
---|---|
JP5764060B2 (en) | 2015-08-12 |
WO2010017885A2 (en) | 2010-02-18 |
EP2309974A2 (en) | 2011-04-20 |
US20140017187A1 (en) | 2014-01-16 |
US20110144130A1 (en) | 2011-06-16 |
EP2309974B1 (en) | 2016-08-31 |
JP2011530546A (en) | 2011-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009118107A3 (en) | Skin care composition | |
WO2010017885A3 (en) | Use of 5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5yl)-3-methyl- penta-2,4-dienoic | |
MX299318B (en) | Topical cosmetic skin lightening compositions and methods of use thereof. | |
GB2431876B (en) | Use of para-coumaric acid or para-hydroxycinnamic acid derivatives in cosmetic or dermatological compositions | |
EP2405886B8 (en) | Topical personal care and pharmaceutical compositions and uses thereof | |
CA2863681A1 (en) | Topical use of a skin-commensal prebiotic agent and compositions containing the same | |
WO2011148328A3 (en) | Cosmetic process for making-up and/or caring for the skin and/or the lips | |
WO2013175221A3 (en) | Composition | |
WO2011000866A3 (en) | Multicomponent glasses for use in personal care products | |
WO2009077471A3 (en) | Azolylmethyloxiranes, use thereof and agents containing the same | |
WO2010092088A3 (en) | Use of hydrophobin as a spreading agent | |
WO2012095399A3 (en) | Personal care compositions | |
WO2009024374A3 (en) | Novel dipolar ionic compounds comprising formulations and the use thereof | |
WO2012002730A3 (en) | Skin-whitening and skin-moisturizing composition containing bee venom extracts | |
BR112012025270A2 (en) | "personal care composition" | |
WO2013004982A3 (en) | Cosmetic treatment processes and kit | |
ZA201104079B (en) | Therapeutic,dietary,or cosmetic use of compounds with specific anti-apoptotic activity toward caspase-3,and compositions containing these compounds | |
WO2008144084A3 (en) | Lotion composition for personal use | |
FR2881349B1 (en) | NOVEL USE OF GALACTOMANNANES AS AN ACTIVE AGENT IN COSMETICS. | |
WO2010078932A3 (en) | Diols as antiperspirant agents | |
WO2014023649A3 (en) | Dermal cosmetic compositions having osmoprotecting activity | |
IT1391663B1 (en) | USE OF COMPOUNDS TO INHIBIT THE ACTIVITY OF THE ENZYME 5ALPHE-REDUCTASE AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS THAT CONTAIN THEM | |
WO2010145919A3 (en) | Cosmetic compositions comprising silver lactate | |
WO2011113785A3 (en) | A cosmetic composition for rejuvenating skin appearance | |
WO2012093973A3 (en) | Compositions in the form of tablets comprising acarbose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09777441 Country of ref document: EP Kind code of ref document: A2 |
|
REEP | Request for entry into the european phase |
Ref document number: 2009777441 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009777441 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13058685 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2011522397 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |